MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders

  • Yuan Y
  • Kasar S
  • Underbayev C
  • et al.
N/ACitations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Common blood disorders include hematopoietic cell malignancies or leukemias and plasma cell dyscrasia, all of which have associated microRNA abnormalities. In this paper, we discuss several leukemias including acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL) and identify altered microRNAs and their targets. Immune disorders with altered blood levels of antibodies include autoimmune disorders, such as systemic lupus erythematosus (SLE) with associated anti-self-autoantibodies and immunoglobulin A nephropathy (IgAN) also have related microRNA abnormalities. The alterations in microRNAs may serve as therapeutic targets in these blood disorders.

Cite

CITATION STYLE

APA

Yuan, Y., Kasar, S., Underbayev, C., Prakash, S., & Raveche, E. (2012). MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders. Leukemia Research and Treatment, 2012, 1–11. https://doi.org/10.1155/2012/603830

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free